Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Clemastine is an antihistamine with sedative and anticholinergic effects used to treat the symptoms of allergic rhinitis. An ethanolamine-derivative, first generation histamine H1 antagonist used in hay fever, rhinitis, allergic skin conditions, and pruritus.
- Mechanism
- Curator reviewed
Clemastine is a selective histamine H1 antagonist and binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.
- Primary indication
- For the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus and acrimation.Curator reviewed · 6 structured indications
- Formula / weight
- C21H26ClNO · 343.89 g/mol (avg)
- First approval
- Canada, 1992 · United States, 1992
- Code names
- HS-592
- Brand names
- Clemsza
- Wal-hist 12 Hr Relief
Resolves to
YNNUSGIPVFPVBX-NHCUHLMSSA-NSMILESCN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Clemastine, and which of those have an active Phase 3 trial?